Should frailty and functional status be assessed before treatment is started? how is it assessed?

Should frailty and functional status be assessed before treatment is started? how is it assessed?
Why is it important to have a BMB before myeloma treatment is started?
BETA What are clonal hematopoiesis of indeterminate potential (CHIP) mutations?